Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelia Schroeder

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncology Letters|December 15, 2018
High expression of class III β-tubulin in upper gastrointestinal cancer typesDoris Höflmayer, Eray Öztürk, Cornelia Schroeder, et al.
Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Acta Oncologica (Stockholm, Sweden)|November 6, 2019
High RSF1 protein expression is an independent prognostic feature in prostate cancerDoris Höflmayer, Moslim Hamuda, Cornelia Schroeder, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Neoplasia (New York, N.Y.)|August 23, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate CancerFrank Jacobsen, Juliane Kraft, Cornelia Schroeder, et al.
Journal of Medical Genetics|June 28, 2020
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk predictionAlice Alessandra Galeotti, Manuel Gentiluomo, Cosmeri Rizzato, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Carcinogenesis|October 14, 2017
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomyMaria Christina Tsourlakis, Agapi Eleftheriadou, Annegret Stender, et al.
The Prostate|November 16, 2018
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancersSarah Minner, Jannes Lutz, Claudia Hube-Magg, et al.
Oncotarget|August 28, 2019
Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomyCornelia Schroeder, Elham Navid-Hill, Jan Meiners, et al.
Oncology Letters|December 15, 2018
High expression of class III β-tubulin in upper gastrointestinal cancer typesDoris Höflmayer, Eray Öztürk, Cornelia Schroeder, et al.
Cancers|March 10, 2022
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic PowerAlexandra M Poos, Cornelia Schroeder, Neeraja Jaishankar, et al.
Oncotarget|January 7, 2020
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusionStefan Steurer, Lara Schwemmer, Claudia Hube-Magg, et al.
Acta Oncologica (Stockholm, Sweden)|November 6, 2019
High RSF1 protein expression is an independent prognostic feature in prostate cancerDoris Höflmayer, Moslim Hamuda, Cornelia Schroeder, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Neoplasia (New York, N.Y.)|August 23, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate CancerFrank Jacobsen, Juliane Kraft, Cornelia Schroeder, et al.
Journal of Medical Genetics|June 28, 2020
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk predictionAlice Alessandra Galeotti, Manuel Gentiluomo, Cosmeri Rizzato, et al.
Pageof 3